MaruMatchbox has appointed former Kantar / MaPs leader Rich Durante as Managing Director of Pharmaceuticals and Medicines, based in Boston.Durante brings more than twenty years' experience of work for life sciences companies and the public health arena, and worked most recently at Kantar where he was Managing Partner for the Brand Strategy Group (formerly MaPS). His work, spread across many therapy areas, includes patient journey studies, consumer and healthcare professional (HCP) segmentation, product/service optimization and forecasting, and HCP brand strategy research. He has also published papers on novel qual and quant methodologies / applications, and general commentaries on medical practice in areas ranging from oncology to immunology.
In his new role, he is responsible for one of Matchbox's fast-growing verticals. Maru Group CEO Ged Parton remarks: 'Rich brings with him a wealth of experience in a range of industries, but his deep sector expertise in life sciences & healthcare are what will lead our clients to make informed, impactful business decisions that move people into action. He is a real asset to the company and I am delighted to welcome him to the team'.
Web site: www.marumatchbox.com .
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online